SCHOTT Pharma AG & Co. KGaA (1SXP.DE)
| Market Cap | n/a+21.6% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,594 |
| Open | n/a |
| Previous Close | 25.15 |
| Day's Range | 24.70 - 25.10 |
| 52-Week Range | 12.62 - 26.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$1SXP.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in 1SXP.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by 1SXP.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
1SXP.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New 1SXP.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to 1SXP.DE from public contracts
Source: USAspending.gov
1SXP.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from 1SXP.DE’s recent data — informational, not investment advice